Noticias de Eulerpool CStone Pharmaceuticals

CStone Pharmaceuticals Eulerpool-AFX

CStone Pharmaceuticals Noticias de Acciones

CStone Pharmaceuticals es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de CStone Pharmaceuticals.

• 30 de septiembre ·

  Yahoo
  High Growth Tech Stocks In Hong Kong To Watch This September 2024
• 2 de septiembre ·

  Yahoo
  High Growth Tech Stocks In Hong Kong Featuring SUNeVision Holdings And Two Others
• 23 de agosto ·

  Yahoo
  CStone Reports 2024 Interim Results and Recent Corporate Updates
• 26 de julio ·

  Yahoo
  CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
• 2 de junio ·

  SeekingAlpha
  Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership
• 2 de junio ·

  Yahoo
  CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
• 26 de mayo ·

  SeekingAlpha
  Week In Review: Hengrui And Dearon Announce $7.2B In Drug Licensings
• 24 de mayo ·

  Yahoo
  CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website
• 27 de marzo ·

  Yahoo
  CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
• 15 de marzo ·

  Yahoo
  CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer